| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 149, 805-819, Copyright © 1996 by American Society for Investigative Pathology
REGULAR ARTICLES |
K Lamszus, A Joseph, L Jin, Y Yao, S Chowdhury, A Fuchs, PJ Polverini, ID Goldberg and EM Rosen
Department of Radiation Oncology, Long Island Jewish Medical Center, New Hyde Park, New York 11040, USA.
Scatter factor (SF) is an angiogenic growth factor that stimulates motility and invasion of carcinoma cells. SF is present in the extracellular matrix (ECM) of breast cancers, where it might act to promote tumor cell invasion and angiogenesis. To investigate how SF is incorporated into the ECM, we studied the binding of SF to various ECM components using a solid-phase binding assay based on the SF enzyme- linked immunosorbent assay. We found that SF binds to a variety of ECM molecules, with different binding capacities. The highest SF binding capacities were observed for thrombospondin-1 (TSP-1), fibronectin (Fn), and heparan sulfate proteoglycan, although SF did not bind to albumin. Mature two-chain SF and precursor single-chain SF bound approximately equally well to TSP-1 and Fn. Moreover, two SF alpha- chain peptides (NK1 and NK2) both bound to TSP-1 and Fn, suggesting that the whole SF molecule is not required for binding. Based on binding competition assays, TSP-1 exhibited higher affinity for SF than did nine other ECM molecules, including Fn and heparan sulfate proteoglycan. Although heparin in solution potently inhibited the binding of SF to TSP-1-coated surfaces, even very high concentrations of heparin could not elute SF already bound to TSP-1. SF binding was modulated by binding interactions among ECM molecules (TSP-1-Fn, TSP-1- collagen I, and Fn-collagen I), suggesting that the matrix capacity to bind SF depends upon its exact composition. SF bound in a dose- dependent fashion to ECMs secreted by three human breast carcinoma cell lines. Binding of SF to matrices from all three cell lines was significantly inhibited by preincubation of the matrices with antibodies against TSP-1, whereas antibodies against several other ECM components were less effective or ineffective in inhibiting SF binding. In addition, TSP-1 markedly inhibited chemotaxis of microvascular endothelial cells toward SF and SF-induced angiogenesis in the rat cornea neovascularization assay. Our findings suggest that 1) SF interacts with a variety of ECM components, 2) high affinity SF-TSP-1 interactions may mediate the binding of SF to the breast cancer matrix, and 3) the SF-TSP-1 interaction may contribute to modulation of angiogenesis. Possible implications of these findings for tumor angiogenesis are discussed.
This article has been cited by other articles:
 |
|
 |
|
  N. Hattori, S. Mizuno, Y. Yoshida, K. Chin, M. Mishima, T. H. Sisson, R. H. Simon, T. Nakamura, and M. Miyake The Plasminogen Activation System Reduces Fibrosis in the Lung by a Hepatocyte Growth Factor-Dependent Mechanism Am. J. Pathol., March 1, 2004; 164(3): 1091 - 1098. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Margosio, D. Marchetti, V. Vergani, R. Giavazzi, M. Rusnati, M. Presta, and G. Taraboletti Thrombospondin 1 as a scavenger for matrix-associated fibroblast growth factor 2 Blood, December 15, 2003; 102(13): 4399 - 4406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-W. Zhang, Y. Su, O. V. Volpert, and G. F. V. Woude Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation PNAS, October 28, 2003; 100(22): 12718 - 12723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kinoshita, T. Miyamoto, N. Ohashi, S. Sasayama, and A. Matsumori Thrombosis Increases Circulatory Hepatocyte Growth Factor by Degranulation of Mast Cells Circulation, December 10, 2002; 106(24): 3133 - 3138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Petrik, P. A. Gentry, J.-J. Feige, and J. LaMarre Expression and Localization of Thrombospondin-1 and -2 and Their Cell-Surface Receptor, CD36, During Rat Follicular Development and Formation of the Corpus Luteum Biol Reprod, November 1, 2002; 67(5): 1522 - 1531. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.S. Lindsey and R. M. Brenner Novel hepatocyte growth factor/scatter factor isoform transcripts in the macaque endometrium and placenta Mol. Hum. Reprod., January 1, 2002; 8(1): 81 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. RUSNATI, G. TARABOLETTI, C. URBINATI, G. TULIPANO, R. GIULIANI, M. P. MOLINARI-TOSATTI, B. SENNINO, M. GIACCA, M. TYAGI, A. ALBINI, et al. Thrombospondin-1/HIV-1 Tat protein interaction: modulation of the biological activity of extracellular Tat FASEB J, October 1, 2000; 14(13): 1917 - 1930. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. Pfander, T. Cramer, D. Deuerling, G. Weseloh, and B. Swoboda Expression of thrombospondin-1 and its receptor CD36 in human osteoarthritic cartilage Ann Rheum Dis, June 1, 2000; 59(6): 448 - 454. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. L. Jakubczak, W. J. Larochelle, and G. Merlino NK1, a Natural Splice Variant of Hepatocyte Growth Factor/Scatter Factor, Is a Partial Agonist In Vivo Mol. Cell. Biol., March 1, 1998; 18(3): 1275 - 1283. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. W. Dawson, S. F. A. Pearce, R. Zhong, R. L. Silverstein, W. A. Frazier, and N. P. Bouck CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells J. Cell Biol., August 11, 1997; 138(3): 707 - 717. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Sergeant, M. Lyon, P. S. Rudland, D. G. Fernig, and M. Delehedde Stimulation of DNA Synthesis and Cell Proliferation of Human Mammary Myoepithelial-like Cells by Hepatocyte Growth Factor/Scatter Factor Depends on Heparan Sulfate Proteoglycans and Sustained Phosphorylation of Mitogen-activated Protein Kinases p42/44 J. Biol. Chem., May 26, 2000; 275(22): 17094 - 17099. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
